Bio-Techne
TECH
$68.43
Share price
-1.33%
Change (1 day)
-30.14%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Bio-Techne (TECH) - Net assets
Net assets on the balance sheet as of June 2023 : $1.96 B
According to Bio-Techne's latest financial reports the company has $1.96 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Bio-Techne - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-06-30 | $1.70 B | 8.26% |
| 2021-06-30 | $1.57 B | 13.76% |
| 2020-06-30 | $1.38 B | 18.5% |
| 2019-06-30 | $1.16 B | 8.01% |
| 2018-06-30 | $1.07 B | 13.5% |
| 2017-06-30 | $0.95 B | 8.14% |
| 2016-06-30 | $0.87 B | 3.82% |
| 2015-06-30 | $0.84 B | 6.5% |
| 2014-06-30 | $0.79 B | 7.83% |
| 2013-06-30 | $0.73 B | 9.36% |
| 2012-06-30 | $0.67 B | 15.07% |
| 2011-06-30 | $0.58 B | 16.81% |
| 2010-06-30 | $0.50 B | 9.93% |
| 2009-06-30 | $0.45 B | -6.29% |
| 2008-06-30 | $0.48 B | 11.31% |
| 2007-06-30 | $0.43 B | 28.59% |
| 2006-06-30 | $0.34 B | 27.06% |
| 2005-06-30 | $0.26 B | -9.94% |
| 2004-06-30 | $0.29 B | 25.7% |
| 2003-06-30 | $0.23 B | 14.58% |
| 2002-06-30 | $0.20 B | 16.24% |
| 2001-06-30 | $0.17 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $43.91 B | 2,133.13% | 🇺🇸 USA |
 Becton Dickinson BDX | $25.93 B | 1,218.93% | 🇺🇸 USA |
 General Electric GE | $32.36 B | 1,545.95% | 🇺🇸 USA |
 Danaher DHR | $51.72 B | 2,530.23% | 🇺🇸 USA |
 Qiagen QGEN | $3.62 B | 84.27% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $18.92 M | -99.04% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $8.44 B | 329.53% | 🇺🇸 USA |